Recent

% | $
Quotes you view appear here for quick access.

Express Scripts Holding Company Message Board

  • bluecheese4u bluecheese4u Feb 18, 2013 8:27 PM Flag

    Express Scripts Reports Fourth Quarter and Full Year Results

    Express Scripts Reports Fourth Quarter and Full Year Results

    Provides Initial 2013 Earnings Guidance

    ST. LOUIS, February 18, 2013 — Express Scripts Holding Company (Nasdaq: ESRX) announced 2012 fourth quarter and full year net income attributable to Express Scripts shareholders from continuing operations of $515.9 million and $1,340.5 million, or $0.62 and $1.79 per diluted share, respectively. Adjusted earnings per share attributable to Express Scripts from continuing operations, as detailed in Table 4 were $1.05 and $3.74 per diluted share for the fourth quarter and full year, respectively.
    “2012 was a monumental year for Express Scripts as we closed the acquisition of Medco and made significant progress integrating the two companies,” stated George Paz, chairman and chief executive officer. “Our financial performance in 2012 was strong, and as we look to the future, we are well positioned to capitalize on the complementary strengths of the combined organization, which enhance our ability to improve health outcomes, lower health care costs and continue to deliver long-term growth.”
    Fourth Quarter 2012 Review (Results from continuing operations on an adjusted basis where indicated. See Tables 2 and 3)
    All key metrics compared to 2011 were affected by the inclusion of Medco results beginning in the second quarter of 2012. Gross profit margin and EBITDA per adjusted claim increases over last year are mainly attributed to improved operating performance, increased generic utilization and realization of synergies.
    Adjusted claims of 410.8 million, up 111% Gross profit of $2.3 billion, up 160% EBITDA of $1.6 billion, up 131% EBITDA per adjusted claim of $4.01, up 10% Cash flow from operations of $2.6 billion, compared to $0.5 billion in the fourth quarter of 2011
    Full Year 2012 Review (Results from continuing operations on an adjusted basis where indicated. See Tables 2 and 3)
    Adjusted claims of 1,395.7 million, up 86% Gross profit of $7.5 billion, up 123%
    EBITDA of $5.4 billion, up 103% EBITDA per adjusted claim of $3.87, up 9% Cash flow from operations of $4.8 billion, including merger-related costs, up from $2.2 billion in 2011
    Due to the Federal Holiday on February 18, 2013, the Company expects to file its Annual Report on Form 10-K for the year ended December 31, 2012 with the Securities and Exchange Commission (“SEC”) on Tuesday, February 19, 2013.

    External Files

    phxDOTcorporate-irDOTnet/ExternalDOTFile?item=UGFyZW50SUQ9MTcyMjIyfENoaWxkSUQ9LTF8VHlwZT0z&t=1

    2012 Express Scripts Recast Worksheet.

    phxDOTcorporate-irDOTnet/ExternalDOTFile?item=UGFyZW50SUQ9MTcyMjIxfENoaWxkSUQ9LTF8VHlwZT0z&t=1

 
ESRX
88.83+0.80(+0.91%)Jul 7 4:00 PMEDT